Nuocytes: Expanding the innate cell repertoire in type-2 immunity

Journal of Leukocyte Biology

Volumn 90, Issue 5, 2011, Pages 867-874

  Barlow, Jillian L ^a   McKenzie, Andrew N J ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

IL 13; IL 25; IL 33

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE RECEPTOR; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 25; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 9;

ADAPTIVE IMMUNITY; ALLERGIC ASTHMA; BETA RHYTHM; CELL DIFFERENTIATION; CELL POPULATION; CELL TYPE; DENDRITIC CELL; HELMINTH; IMMUNE RESPONSE; INNATE IMMUNITY; NONHUMAN; NUOCYTE; OBSERVATION; PARASITE; PRIORITY JOURNAL; REVIEW; TARGET CELL; TH1 CELL; TH2 CELL; UPREGULATION;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, HELMINTH; HELMINTHIASIS; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-17; INTERLEUKINS; LYMPHOTOXIN-ALPHA; T-LYMPHOCYTE SUBSETS; TH1 CELLS; TH2 CELLS;

BACTERIA (MICROORGANISMS);

EID: 80055068380     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0311160     Document Type: Review

References (80)

1. Flynn, J. L., Chan, J., Triebold, K. J., Dalton, D. K., Stewart, T. A., Bloom, B. R. (1993) An essential role for interferon γ in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178, 2249-2254.
2. Lehuen, A., Diana, J., Zaccone, P., Cooke, A. (2010) Immune cell crosstalk in type 1 diabetes. Nat. Rev. Immunol. 10, 501-513.
3. Skapenko, A., Leipe, J., Lipsky, P. E., Schulze-Koops, H. (2005) The role of the T cell in autoimmune inflammation. Arthritis Res. Ther. 7 (Suppl. 2), S4-S14.
4. Fallon, P. G., Jolin, H. E., Smith, P., Emson, C. L., Townsend, M. J., Fallon, R., McKenzie, A. N. (2002) IL-4 induces characteristic Th2 responses even in the combined absence of IL-5, IL-9, and IL-13. Immunity 17, 7-17.
5. McKenzie, G. J., Fallon, P. G., Emson, C. L., Grencis, R. K., McKenzie, A. N. (1999) Simultaneous disruption of interleukin (IL)-4 and IL-13 defines individual roles in T helper cell type 2-mediated responses. J. Exp. Med. 189, 1565-1572.
6. Stockinger, B., Veldhoen, M. (2007) Differentiation and function of Th17 T cells. Curr. Opin. Immunol. 19, 281-286.
7. Hirota, K., Duarte, J. H., Veldhoen, M., Hornsby, E., Li, Y., Cua, D. J., Ahlfors, H., Wilhelm, C., Tolaini, M., Menzel, U., Garefalaki, A., Potocnik, A. J., Stockinger, B. (2011) Fate mapping of IL-17-producing T cells in inflammatory responses. Nat. Immunol. 12, 255-263.
8. Nembrini, C., Abel, B., Kopf, M., Marsland, B. J. (2006) Strong TCR signaling, TLR ligands, and cytokine redundancies ensure robust development of type 1 effector T cells. J. Immunol. 176, 7180-7188.
9. Cooper, A. M., Magram, J., Ferrante, J., Orme, I. M. (1997) Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J. Exp. Med. 186, 39-45.
10. Trinchieri, G. (2003) Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3, 133-146.
11. McKenzie, G. J., Emson, C. L., Bell, S. E., Anderson, S., Fallon, P., Zurawski, G., Murray, R., Grencis, R., McKenzie, A. N. (1998) Impaired development of Th2 cells in IL-13-deficient mice. Immunity 9, 423-432.
12. Paul, W. E. (2010) What determines Th2 differentiation, in vitro and in vivo? Immunol. Cell Biol. 88, 236-239.
13. Voehringer, D., Reese, T. A., Huang, X., Shinkai, K., Locksley, R. M. (2006) Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system. J. Exp. Med. 203, 1435-1446.
14. Walter, D. M., McIntire, J. J., Berry, G., McKenzie, A. N., Donaldson, D. D., DeKruyff, R. H., Umetsu, D. T. (2001) Critical role for IL-13 in the development of allergen-induced airway hyperreactivity. J. Immunol. 167, 4668-4675.
15. Fort, M. M., Cheung, J., Yen, D., Li, J., Zurawski, S. M., Lo, S., Menon, S., Clifford, T., Hunte, B., Lesley, R., Muchamuel, T., Hurst, S. D., Zurawski, G., Leach, M. W., Gorman, D. M., Rennick, D. M. (2001) IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 15, 985-995.
16. Schmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G., Moshrefi, M., Qin, J., Li, X., Gorman, D. M., Bazan, J. F., Kastelein, R. A. (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23, 479-490.
17. Pan, G., French, D., Mao, W., Maruoka, M., Risser, P., Lee, J., Foster, J., Aggarwal, S., Nicholes, K., Guillet, S., Schow, P., Gurney, A. L. (2001) Forced expression of murine IL-17E induces growth retardation, jaundice, a Th2-biased response, and multiorgan inflammation in mice. J. Immunol. 167, 6559-6567.
18. Fallon, P. G., Ballantyne, S. J., Mangan, N. E., Barlow, J. L., Dasvarma, A., Hewett, D. R., McIlgorm, A., Jolin, H. E., McKenzie, A. N. (2006) Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. J. Exp. Med. 203, 1105-1116.
19. Oboki, K., Ohno, T., Kajiwara, N., Arae, K., Morita, H., Ishii, A., Nambu, A., Abe, T., Kiyonari, H., Matsumoto, K., Sudo, K., Okumura, K., Saito, H., Nakae, S. (2010) IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc. Natl. Acad. Sci. USA 107, 18581-18586.
20. Neill, D. R., Wong, S. H., Bellosi, A., Flynn, R. J., Daly, M., Langford, T. K., Bucks, C., Kane, C. M., Fallon, P. G., Pannell, R., Jolin, H. E., McKenzie, A. N. (2010) Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464, 1367-1370.
21. Hurst, S. D., Muchamuel, T., Gorman, D. M., Gilbert, J. M., Clifford, T., Kwan, S., Menon, S., Seymour, B., Jackson, C., Kung, T. T., Brieland, J. K., Zurawski, S. M., Chapman, R. W., Zurawski, G., Coffman, R. L. (2002) New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25. J. Immunol. 169, 443-453.
22. Rickel, E. A., Siegel, L. A., Yoon, B. R., Rottman, J. B., Kugler, D. G., Swart, D. A., Anders, P. M., Tocker, J. E., Comeau, M. R., Budelsky, A. L. (2008) Identification of functional roles for both IL-17RB and IL-17RA in mediating IL-25-induced activities. J. Immunol. 181, 4299-4310.
23. Ikeda, K., Nakajima, H., Suzuki, K., Kagami, S., Hirose, K., Suto, A., Saito, Y., Iwamoto, I. (2003) Mast cells produce interleukin-25 upon Fc ε RImediated activation. Blood 101, 3594-3596.
24. Kang, C. M., Jang, A. S., Ahn, M. H., Shin, J. A., Kim, J. H., Choi, Y. S., Rhim, T. Y., Park, C. S. (2005) Interleukin-25 and interleukin-13 production by alveolar macrophages in response to particles. Am. J. Respir. Cell Mol. Biol. 33, 290-296.
25. Wang, Y. H., Angkasekwinai, P., Lu, N., Voo, K. S., Arima, K., Hanabuchi, S., Hippe, A., Corrigan, C. J., Dong, C., Homey, B., Yao, Z., Ying, S., Huston, D. P., Liu, Y. J. (2007) IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells. J. Exp. Med. 204, 1837-1847.
26. Terashima, A., Watarai, H., Inoue, S., Sekine, E., Nakagawa, R., Hase, K., Iwamura, C., Nakajima, H., Nakayama, T., Taniguchi, M. (2008) A novel subset of mouse NKT cells bearing the IL-17 receptor B responds to IL-25 and contributes to airway hyperreactivity. J. Exp. Med. 205, 2727-2733.
27. Stock, P., Lombardi, V., Kohlrautz, V., Akbari, O. (2009) Induction of airway hyperreactivity by IL-25 is dependent on a subset of invariant NKT cells expressing IL-17RB. J. Immunol. 182, 5116-5122.
28. Carriere, V., Roussel, L., Ortega, N., Lacorre, D. A., Americh, L., Aguilar, L., Bouche, G., Girard, J. P. (2007) IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc. Natl. Acad. Sci. USA 104, 282-287.
29. Löhning, M., Stroehmann, A., Coyle, A. J., Grogan, J. L., Lin, S., Gutierrez-Ramos, J. C., Levinson, D., Radbruch, A., Kamradt, T. (1998) T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc. Natl. Acad. Sci. USA 95, 6930-6935.
30. Allakhverdi, Z., Smith, D. E., Comeau, M. R., Delespesse, G. (2007) Cutting edge: the ST2 ligand IL-33 potently activates and drives maturation of human mast cells. J. Immunol. 179, 2051-2054.
31. Pecaric-Petkovic, T., Didichenko, S. A., Kaempfer, S., Spiegl, N., Dahinden, C. A. (2009) Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33. Blood 113, 1526-1534.
32. Angkasekwinai, P., Park, H., Wang, Y. H., Chang, S. H., Corry, D. B., Liu, Y. J., Zhu, Z., Dong, C. (2007) Interleukin 25 promotes the initiation of proallergic type 2 responses. J. Exp. Med. 204, 1509-1517.
33. Préfontaine, D., Lajoie-Kadoch, S., Foley, S., Audusseau, S., Olivenstein, R., Halayko, A. J., Lemiere, C., Martin, J. G., Hamid, Q. (2009) Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. J. Immunol. 183, 5094-5103.
34. Moussion, C., Ortega, N., Girard, J. P. (2008) The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel "alarmin"? PLoS ONE 3, e3331.
35. Moro, K., Yamada, T., Tanabe, M., Takeuchi, T., Ikawa, T., Kawamoto, H., Furusawa, J., Ohtani, M., Fujii, H., Koyasu, S. (2010) Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 463, 540-544.
36. Price, A. E., Liang, H. E., Sullivan, B. M., Reinhardt, R. L., Eisley, C. J., Erle, D. J., Locksley, R. M. (2010) Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc. Natl. Acad. Sci. USA 107, 11489-11494.
37. Price, A. J., Allen, N. E., Appleby, P. N., Crowe, F. L., Jenab, M., Rinaldi, S., Slimani, N., Kaaks, R., Rohrmann, S., Boeing, H., Pischon, T., Benetou, V., Naska, A., Trichopoulou, A., Palli, D., Sieri, S., Tumino, R., Vineis, P., Bueno-de-Mesquita, H. B., Donate, I., Gonzalez, C. A., Sanchez, M. J., Chirlaque, M. D., Ardanaz, E., Larranaga, N., Khaw, K. T., Rodwell, S., Gallo, V., Michaud, D. S., Riboli, E., Key, T. J. (2010) Plasma phytanic acid concentration and risk of prostate cancer: results from the European Prospective Investigation into Cancer and Nutrition. Am. J. Clin. Nutr. 91, 1769-1776.
38. Saenz, S. A., Siracusa, M. C., Perrigoue, J. G., Spencer, S. P., Urban Jr., J. F., Tocker, J. E., Budelsky, A. L., Kleinschek, M. A., Kastelein, R. A., Kambayashi, T., Bhandoola, A., Artis, D. (2010) IL-25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses. Nature 464, 1362-1366.
39. Saenz, S. A., Noti, M., Artis, D. (2010) Innate immune cell populations function as initiators and effectors in Th2 cytokine responses. Trends Immunol. 31, 407-413.
40. von Freeden-Jeffry, U., Vieira, P., Lucian, L. A., McNeil, T., Burdach, S. E., Murray, R. (1995) Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp. Med. 181, 1519-1526.
41. Peschon, J. J., Morrissey, P. J., Grabstein, K. H., Ramsdell, F. J., Maraskovsky, E., Gliniak, B. C., Park, L. S., Ziegler, S. F., Williams, D. E., Ware, C. B., Meyer, J. D., Davison, B. L. (1994) Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J. Exp. Med. 180, 1955-1960.
42. Matloubian, M., David, A., Engel, S., Ryan, J. E., Cyster, J. G. (2000) A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat. Immunol. 1, 298-304.
43. van der Voort, R., Verweij, V., de Witte, T. M., Lasonder, E., Adema, G. J., Dolstra, H. (2010) An alternatively spliced CXCL16 isoform expressed by dendritic cells is a secreted chemoattractant for CXCR6+ cells. J. Leukoc. Biol. 87, 1029-1039.
44. Geissmann, F., Cameron, T. O., Sidobre, S., Manlongat, N., Kronenberg, M., Briskin, M. J., Dustin, M. L., Littman, D. R. (2005) Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids. PLoS Biol. 3, e113.
45. Germanov, E., Veinotte, L., Cullen, R., Chamberlain, E., Butcher, E. C., Johnston, B. (2008) Critical role for the chemokine receptor CXCR6 in homeostasis and activation of CD1d-restricted NKT cells. J. Immunol. 181, 81-91.
46. Paust, S., Gill, H. S., Wang, B. Z., Flynn, M. P., Moseman, E. A., Senman, B., Szczepanik, M., Telenti, A., Askenase, P. W., Compans, R. W., von Andrian, U. H. (2010) Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nat. Immunol. 11, 1127-1135.
47. Zou, Y. R., Kottmann, A. H., Kuroda, M., Taniuchi, I., Littman, D. R. (1998) Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393, 595-599.
48. Odemis, V., Lamp, E., Pezeshki, G., Moepps, B., Schilling, K., Gierschik, P., Littman, D. R., Engele, J. (2005) Mice deficient in the chemokine receptor CXCR4 exhibit impaired limb innervation and myogenesis. Mol. Cell. Neurosci. 30, 494-505.
49. Nagasawa, T., Kikutani, H., Kishimoto, T. (1994) Molecular cloning and structure of a pre-B-cell growth-stimulating factor. Proc. Natl. Acad. Sci. USA 91, 2305-2309.
50. Nie, Y., Waite, J., Brewer, F., Sunshine, M. J., Littman, D. R., Zou, Y. R. (2004) The role of CXCR4 in maintaining peripheral B cell compartments and humoral immunity. J. Exp. Med. 200, 1145-1156.
51. Hu, J. S., Freeman, C. M., Stolberg, V. R., Chiu, B. C., Bridger, G. J., Fricker, S. P., Lukacs, N. W., Chensue, S. W. (2006) AMD3465, a novel CXCR4 receptor antagonist, abrogates schistosomal antigen-elicited (type-2) pulmonary granuloma formation. Am. J. Pathol. 169, 424-432.
52. Wurbel, M. A., Philippe, J. M., Nguyen, C., Victorero, G., Freeman, T., Wooding, P., Miazek, A., Mattei, M. G., Malissen, M., Jordan, B. R., Malissen, B., Carrier, A., Naquet, P. (2000) The chemokine TECK is expressed by thymic and intestinal epithelial cells and attracts double-and singlepositive thymocytes expressing the TECK receptor CCR9. Eur. J. Immunol. 30, 262-271.
53. Wurbel, M. A., Malissen, M., Guy-Grand, D., Meffre, E., Nussenzweig, M. C., Richelme, M., Carrier, A., Malissen, B. (2001) Mice lacking the CCR9 CC-chemokine receptor show a mild impairment of early T-and B-cell development and a reduction in T-cell receptor γδ(+) gut intraepithelial lymphocytes. Blood 98, 2626-2632.
54. Wurbel, M. A., Malissen, M., Guy-Grand, D., Malissen, B., Campbell, J. J. (2007) Impaired accumulation of antigen-specific CD8 lymphocytes in chemokine CCL25-deficient intestinal epithelium and lamina propria. J. Immunol. 178, 7598-7606.
55. Zlotoff, D. A., Sambandam, A., Logan, T. D., Bell, J. J., Schwarz, B. A., Bhandoola, A. (2010) CCR7 and CCR9 together recruit hematopoietic progenitors to the adult thymus. Blood 115, 1897-1905.
56. Uehara, S., Grinberg, A., Farber, J. M., Love, P. E. (2002) A role for CCR9 in T lymphocyte development and migration. J. Immunol. 168, 2811-2819.
57. Pabst, O., Ohl, L., Wendland, M., Wurbel, M. A., Kremmer, E., Malissen, B., Forster, R. (2004) Chemokine receptor CCR9 contributes to the localization of plasma cells to the small intestine. J. Exp. Med. 199, 411-416.
58. Chen, Q., Ghilardi, N., Wang, H., Baker, T., Xie, M. H., Gurney, A., Grewal, I. S., de Sauvage, F. J. (2000) Development of Th1-type immune responses requires the type I cytokine receptor TCCR. Nature 407, 916-920.
59. Yoshida, H., Hamano, S., Senaldi, G., Covey, T., Faggioni, R., Mu, S., Xia, M., Wakeham, A. C., Nishina, H., Potter, J., Saris, C. J., Mak, T. W. (2001) WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. Immunity 15, 569-578.
60. Pflanz, S., Timans, J. C., Cheung, J., Rosales, R., Kanzler, H., Gilbert, J., Hibbert, L., Churakova, T., Travis, M., Vaisberg, E., Blumenschein, W. M., Mattson, J. D., Wagner, J. L., To, W., Zurawski, S., McClanahan, T. K., Gorman, D. M., Bazan, J. F., de Waal Malefyt, R., Rennick, D., Kastelein, R. A. (2002) IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 16, 779-790.
61. Villarino, A., Hibbert, L., Lieberman, L., Wilson, E., Mak, T., Yoshida, H., Kastelein, R. A., Saris, C., Hunter, C. A. (2003) The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. Immunity 19, 645-655.
62. Artis, D., Villarino, A., Silverman, M., He, W., Thornton, E. M., Mu, S., Summer, S., Covey, T. M., Huang, E., Yoshida, H., Koretzky, G., Goldschmidt, M., Wu, G. D., de Sauvage, F., Miller, H. R., Saris, C. J., Scott, P., Hunter, C. A. (2004) The IL-27 receptor (WSX-1) is an inhibitor of innate and adaptive elements of type 2 immunity. J. Immunol. 173, 5626-5634.
63. Miyazaki, Y., Inoue, H., Matsumura, M., Matsumoto, K., Nakano, T., Tsuda, M., Hamano, S., Yoshimura, A., Yoshida, H. (2005) Exacerbation of experimental allergic asthma by augmented Th2 responses in WSX-1-deficient mice. J. Immunol. 175, 2401-2407.
64. Berlin, C., Berg, E. L., Briskin, M. J., Andrew, D. P., Kilshaw, P. J., Holzmann, B., Weissman, I. L., Hamann, A., Butcher, E. C. (1993) α 4 β 7 Integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 74, 185-195.
65. Wagner, N., Lohler, J., Kunkel, E. J., Ley, K., Leung, E., Krissansen, G., Rajewsky, K., Muller, W. (1996) Critical role for β7 integrins in formation of the gut-associated lymphoid tissue. Nature 382, 366-370.
66. Gorfu, G., Rivera-Nieves, J., Ley, K. (2009) Role of β7 integrins in intestinal lymphocyte homing and retention. Curr. Mol. Med. 9, 836-850.
67. Hamann, A., Andrew, D. P., Jablonski-Westrich, D., Holzmann, B., Butcher, E. C. (1994) Role of α 4-integrins in lymphocyte homing to mucosal tissues in vivo. J. Immunol. 152, 3282-3293.
68. Schön, M. P., Arya, A., Murphy, E. A., Adams, C. M., Strauch, U. G., Agace, W. W., Marsal, J., Donohue, J. P., Her, H., Beier, D. R., Olson, S., Lefrancois, L., Brenner, M. B., Grusby, M. J., Parker, C. M. (1999) Mucosal T lymphocyte numbers are selectively reduced in integrin α E (CD103)-deficient mice. J. Immunol. 162, 6641-6649.
69. Artis, D., Humphreys, N. E., Potten, C. S., Wagner, N., Muller, W., Mc-Dermott, J. R., Grencis, R. K., Else, K. J. (2000) β7 Integrin-deficient mice: delayed leukocyte recruitment and attenuated protective immunity in the small intestine during enteric helminth infection. Eur. J. Immunol. 30, 1656-1664.
70. Hutloff, A., Dittrich, A. M., Beier, K. C., Eljaschewitsch, B., Kraft, R., Anagnostopoulos, I., Kroczek, R. A. (1999) ICOS is an inducible T-cell costimulator structurally and functionally related to CD28. Nature 397, 263-266.
71. Yoshinaga, S. K., Whoriskey, J. S., Khare, S. D., Sarmiento, U., Guo, J., Horan, T., Shih, G., Zhang, M., Coccia, M. A., Kohno, T., Tafuri-Bladt, A., Brankow, D., Campbell, P., Chang, D., Chiu, L., Dai, T., Duncan, G., Elliott, G. S., Hui, A., McCabe, S. M., Scully, S., Shahinian, A., Shaklee, C. L., Van, G., Mak, T. W., Senaldi, G. (1999) T-cell co-stimulation through B7RP-1 and ICOS. Nature 402, 827-832.
72. Tafuri, A., Shahinian, A., Bladt, F., Yoshinaga, S. K., Jordana, M., Wakeham, A., Boucher, L. M., Bouchard, D., Chan, V. S., Duncan, G., Odermatt, B., Ho, A., Itie, A., Horan, T., Whoriskey, J. S., Pawson, T., Penninger, J. M., Ohashi, P. S., Mak, T. W. (2001) ICOS is essential for effective T-helper-cell responses. Nature 409, 105-109.
73. Dong, C., Juedes, A. E., Temann, U. A., Shresta, S., Allison, J. P., Ruddle, N. H., Flavell, R. A. (2001) ICOS co-stimulatory receptor is essential for T-cell activation and function. Nature 409, 97-101.
74. Dong, C., Temann, U. A., Flavell, R. A. (2001) Cutting edge: critical role of inducible costimulator in germinal center reactions. J. Immunol. 166, 3659-3662.
75. Nurieva, R. I., Mai, X. M., Forbush, K., Bevan, M. J., Dong, C. (2003) B7h is required for T cell activation, differentiation, and effector function. Proc. Natl. Acad. Sci. USA 100, 14163-14168.
76. Qian, X., Agematsu, K., Freeman, G. J., Tagawa, Y., Sugane, K., Hayashi, T. (2006) The ICOS-ligand B7-H2, expressed on human type II alveolar epithelial cells, plays a role in the pulmonary host defense system. Eur. J. Immunol. 36, 906-918.
77. Kadkhoda, K., Wang, S., Fan, Y., Qiu, H., Basu, S., Halayko, A. J., Yang, X. (2011) ICOS ligand expression is essential for allergic airway hyperresponsiveness. Int. Immunol. 23, 239-249.
78. Buonocore, S., Ahern, P. P., Uhlig, H. H., Ivanov, I. I., Littman, D. R., Maloy, K. J., Powrie, F. (2010) Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 464, 1371-1375.
79. Cella, M., Fuchs, A., Vermi, W., Facchetti, F., Otero, K., Lennerz, J. K., Doherty, J. M., Mills, J. C., Colonna, M. (2009) A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457, 722-725.
80. Allakhverdi, Z., Comeau, M. R., Smith, D. E., Toy, D., Endam, L. M., Desrosiers, M., Liu, Y. J., Howie, K. J., Denburg, J. A., Gauvreau, G. M., Delespesse, G. (2009) CD34+ hemopoietic progenitor cells are potent effectors of allergic inflammation. J. Allergy Clin. Immunol. 123, 472-478.